Global Continuous Subcutaneous Insulin Infusion (CSII) Pump Market Growth 2025-2031

The global Continuous Subcutaneous Insulin Infusion (CSII) Pump market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Insulin pump is an effective means of blood sugar management for diabetic patients. It is a micro-precise, continuously controllable subcutaneous insulin injection tool that can better simulate the physiological insulin secretion pattern. Obtaining the basis for adjusting the dose of insulin pump therapy through blood glucose monitoring is particularly important for diabetic patients characterized by endogenous insulin deficiency. The continuous glucose monitoring (CGM) system can facilitate continuous monitoring of blood glucose and thereby adjust the infusion dosage of the insulin pump.

Compared to a syringe or pen, an insulin pump provides a smooth and continuous infusion to maintain blood sugar stability throughout the day. CGM and insulin pump are two very important technologies in the diagnosis and treatment of diabetes today. They are often used together in clinical practice, called CGM&CSII therapy. The development of "double C" technology promotes the advancement of diabetes diagnosis and treatment technology.

United States market for Continuous Subcutaneous Insulin Infusion (CSII) Pump is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Continuous Subcutaneous Insulin Infusion (CSII) Pump is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Continuous Subcutaneous Insulin Infusion (CSII) Pump is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Continuous Subcutaneous Insulin Infusion (CSII) Pump players cover Medtronic, Tandem Diabetes Care, Insulet, SOOIL, LenoMed Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Continuous Subcutaneous Insulin Infusion (CSII) Pump Industry Forecast” looks at past sales and reviews total world Continuous Subcutaneous Insulin Infusion (CSII) Pump sales in 2024, providing a comprehensive analysis by region and market sector of projected Continuous Subcutaneous Insulin Infusion (CSII) Pump sales for 2025 through 2031. With Continuous Subcutaneous Insulin Infusion (CSII) Pump sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Continuous Subcutaneous Insulin Infusion (CSII) Pump industry.

This Insight Report provides a comprehensive analysis of the global Continuous Subcutaneous Insulin Infusion (CSII) Pump landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Continuous Subcutaneous Insulin Infusion (CSII) Pump portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Continuous Subcutaneous Insulin Infusion (CSII) Pump market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Continuous Subcutaneous Insulin Infusion (CSII) Pump and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Continuous Subcutaneous Insulin Infusion (CSII) Pump.

This report presents a comprehensive overview, market shares, and growth opportunities of Continuous Subcutaneous Insulin Infusion (CSII) Pump market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Tethered Pump
Patch Pump (Micro Pump)

Segmentation by Application:
Type I Diabetes
Type II Diabetes
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Medtronic
Tandem Diabetes Care
Insulet
SOOIL
LenoMed Medical
Omnipod
Roche
Royal Fornia Medical Equipment
Beijing Maishitong Technology
Shanghai MicroPort Medical
Wuxi Apex Medical
Microtech Medical
Phray Medical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Continuous Subcutaneous Insulin Infusion (CSII) Pump market?

What factors are driving Continuous Subcutaneous Insulin Infusion (CSII) Pump market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Continuous Subcutaneous Insulin Infusion (CSII) Pump market opportunities vary by end market size?

How does Continuous Subcutaneous Insulin Infusion (CSII) Pump break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.